Close

Celldex Provides Corporate Update and Reports Second Quarter 2019 Results Aug 7, 2019 04:01PM
Celldex Provides Corporate Update and Reports Full Year 2016 Results Mar 14, 2017 04:01PM
Streetinsider.com's Hot Lunchtime Reads 3/7: (CLDX) (NFLX) (SCOR) (ARO) (WFM) Mar 7, 2016 12:22PM
Pre-Open Stock Movers 2/25: (BNFT) (SSF) (SFXE) Higher; (SLCA) (LC) (SAM) (HPQ) Lower (more...) Feb 25, 2015 09:37AM
Notable 52-Week Highs and Lows of the Day 09/23: (SRPT) (CLDX) (NFLX) High; (LLEN) (TWGP) Low Sep 23, 2013 03:03PM


Jul 3, 2013 10:28AM Notable Analyst Rating Changes 07/03: (ZION) (LEAP) (AN) Upgraded; (MJN) (ACCO) (AA) Downgraded
Aug 17, 2011 07:35AM Needham & Company Maintains a 'Buy' on Celldex Therapeutics (CLDX); Management Focus Grows on Upcoming Phase 3 Rindopepimut Trial Initiation
Jun 23, 2011 07:35AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Five Themes Emerged That We Believe Deserve Increased Attention
May 5, 2011 08:19AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Pivotal Trial of Rindopepimut in GBM On Track to Start in 2H11
Apr 12, 2011 07:39AM Needham & Company on Biotechnology & Life Sciences: Oncology / Hematology Review from the 2011 Needham Healthcare Conference
Mar 4, 2011 08:44AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); As CLDX Prepares to Start a Pivotal Trial of Rindopepimut in GBM, CDX-011 in Breast Cancer (Phase 2b) & Other Pipeline Products Adv
Jan 5, 2011 08:03AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); As the Company Prepares to Start a Pivotal Trial of Rindopepimut in GBM, Other Pipeline Products Continue to Advance
Nov 22, 2010 07:59AM Needham & Company reiterates a 'Buy' on Celldex Therapeutics (CLDX); Freezing Weather/Warming Data - Phase 2 Results Presented at the Montreal SNO Meeting Confirm Rindopepimut Potential
Aug 5, 2010 08:08AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Internal Phase 2 Programs Continue to Advance
May 21, 2010 10:25AM 2010 ASCO Meeting Preview - Needham & Co Highlights ArQule (ARQL), Celldex (CLDX), Pharmacyclics (PCYC), and Seattle Genetics (SGEN)
Mar 5, 2010 08:12AM Needham & Company Reiterates a 'Buy' on Celldex Therapeutics (CLDX); Lowers PT
Jul 23, 2009 10:01AM Needham Comments on "Who's Next" In Biotech After Bristol-Myers (BMY) Buys Medarex (MEDX)
May 5, 2009 02:20PM Needham & Co. Upgrades Celldex Therapeutics (CLDX) to Buy
Dec 19, 2008 11:43AM Needham & Co Downgrades Celldex Therapeutics (CLDX) to Hold